• Veterans Affairs Sets New Regulations For Marketing Practices

    The US Department of Veterans Affairs (VA) issued a new regulation on 9 March that restricts access to facilities owned by the VA. Representatives of pharmaceutical companies will be subject to much stricter regulations governing their ability to engage in promotional, educational and conversational activities with VA staff. Pharmaceutical representatives will be required to: Disclose their company ties at the beginning of talks Portray all information accurately Giv...
  • Report: As Pharma Goes Global, So Do Charges of Corruption

    • 29 February 2012
    A report by Reuters has found that increasingly global pharmaceutical companies are running up against many of the same charges of influence peddling and corruption abroad that they once faced at home. The charges could affect more than just the companies' reputations. "In recent years, Big Pharma has forked out billions of dollars to settle scandals involving improper promotion of medicines in the United States.  Now bribes paid to foreign doctors and other st...
  • Industry: GDP Guidelines Would Increase EU Costs

    • 22 February 2012
    Big pharmaceutical and logistics companies say draft good distribution practice (GDP) guidelines from the European Commission would "significantly increase the cost of medicinal product supply chains," according to a published report by Outsourcing Pharma .  The statement is attributed UPS, a worldwide shipper, that is concerned about the classification of any period when products are held at a site for longer than 24 hours as a regulated activity.  The r...
  • US FDA Importing Unapproved Drugs to Ease Shortages

    US Food and Drug Administration (FDA) Commissioner Margaret Hamburg announced at a press conference on 21 February that the agency is working with manufacturers to resolve drug supply shortages of the cancer drugs Doxil (doxorubicin) and methotrexate. Hamburg said the agency is working with domestic and foreign manufacturers to bring supply levels of both drugs back to non-shortage levels, adding that the agency has allowed the import of an unapproved replacement of Dox...